Senior insider sale
EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$4.57M
62.13K shares
What this filing means
KORDASIEWICZ HOLLY B. plans to sell 62.13K shares of IONIS PHARMACEUTICALS INC valued at approximately $4.57M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001972481-26-000226
Officer· EVP, Chief Development Officer
Since Dec 2025
62.13K
Shares to sell
$4.57M
Approx. market value
1.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Equity Compensation
1/15/2021
1.29KTotal acquired1.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2021 | Restricted Stock Equity Compensation | 1.29K | — |
| Total | 1.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
60.85K
Market value
$4.47M
6/12/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.29K
Market value
$108.5K
7/7/2026
Total
Units
62.13K
Value
$4.57M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/12/2026 | 60.85K | $4.47M | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 1.29K | $108.5K | Nasdaq | Planned |
| Total | 62.13K | $4.57M | ||